Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse

滥用药物的药代动力学和药效学

基本信息

项目摘要

There are many factors that influence the addictiveness of a drug. The route of administration is a major determinant of the speed of drug entry into the body and to receptors in the central nervous system. Clinical studies are in progress which determine the importance of different routes of administration and the relationship of blood concentrations of drug and active metabolites to concomitant drug effects. Studies of heroin, cocaine, methamphetamine, codeine and cannabis administration by the intravenous, smoked, intranasal and oral routes are underway or in the data analysis stage. Pharmacodynamic effects include subjective, cognitive and psychomotor performance, physiological measures and specific brain activity as assessed by fMRI. Plasma, urine, oral fluid, sweat, hair and skin are analyzed for drug and metabolites by solid phase extraction-gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry. The intravenous and smoked routes produce a rapid onset of pharmacological effects together with an early appearance of drug and metabolites in blood. Evidence of delays in distribution to effector sites are observed following cannabis smoking, but drug effects following heroin and cocaine administration coincided more closely with concurrent blood concentrations. Onset of effects is delayed following intranasal and especially after oral administration.
有许多因素会影响药物的成瘾性。给药途径是药物进入体内和进入中枢神经系统受体的速度的主要决定因素。 正在进行临床研究,以确定不同给药途径的重要性以及药物和活性代谢物的血药浓度与伴随药物效应的关系。关于通过静脉注射、烟熏、鼻内和口服途径给予海洛因、可卡因、甲基苯丙胺、可待因和大麻的研究正在进行或处于数据分析阶段。 药效学作用包括通过fMRI评估的主观、认知和精神运动表现、生理指标和特定大脑活动。通过固相萃取-气相色谱/质谱法和液相色谱/质谱法分析血浆、尿液、口腔液、汗液、毛发和皮肤中的药物和代谢物。 静脉注射和烟熏途径产生快速起效的药理作用,同时药物和代谢物在血液中较早出现。在吸食大麻后观察到延迟分布到效应部位的证据,但海洛因和可卡因给药后的药物效应与同时发生的血液浓度更密切地吻合。鼻内给药后,尤其是口服给药后,起效延迟。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.
利莫那班对健康人模拟公开演讲引起的焦虑的影响:初步报告。
  • DOI:
    10.1002/hup.2374
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bergamaschi,MateusM;Queiroz,ReginaHC;Chagas,MarcosHN;Linares,IlaMP;Arrais,KátiaC;deOliveira,DanielleCG;Queiroz,MariaE;Nardi,AntonioE;Huestis,MarilynA;Hallak,JaimeEC;Zuardi,AntonioW;Moreira,FabrícioA;Crippa,JoséA
  • 通讯作者:
    Crippa,JoséA
Altering the landscape for women in clinical chemistry: perspectives from multigenerational leaders.
改变临床化学领域女性的前景:多代领导人的观点。
  • DOI:
    10.1373/clinchem.2011.174284
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    9.3
  • 作者:
    Haymond,Shannon;Saenger,AmyK;Free,HelenM;Hicks,JocelynM;Huestis,MarilynA;Horvath,AndreaRita;Fantz,CorinneR
  • 通讯作者:
    Fantz,CorinneR
Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.
  • DOI:
    10.1007/s00216-011-5197-7
  • 发表时间:
    2011-09
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Schwope, David M.;Scheidweiler, Karl B.;Huestis, Marilyn A.
  • 通讯作者:
    Huestis, Marilyn A.
Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search.
  • DOI:
    10.1021/ac3037365
  • 发表时间:
    2013-04-02
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Wohlfarth, Ariane;Scheidweiler, Karl B.;Chen, Xiaohong;Liu, Hua-fen;Huestis, Marilyn A.
  • 通讯作者:
    Huestis, Marilyn A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl Scheidweiler其他文献

Karl Scheidweiler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl Scheidweiler', 18)}}的其他基金

Role of multidrug resistance protein 1a (MDR1a) in methamphetamine and methylened
多药耐药蛋白 1a (MDR1a) 在甲基苯丙胺和亚甲基中的作用
  • 批准号:
    7966918
  • 财政年份:
  • 资助金额:
    $ 29.98万
  • 项目类别:
Role of multidrug resistance protein 1a (MDR1a) in methamphetamine and methylened
多药耐药蛋白 1a (MDR1a) 在甲基苯丙胺和亚甲基中的作用
  • 批准号:
    8148564
  • 财政年份:
  • 资助金额:
    $ 29.98万
  • 项目类别:
Role of multidrug resistance protein 1a (MDR1a) in methamphetamine and methylened
多药耐药蛋白 1a (MDR1a) 在甲基苯丙胺和亚甲基中的作用
  • 批准号:
    7733836
  • 财政年份:
  • 资助金额:
    $ 29.98万
  • 项目类别:
Detection Of Drugs Of Abuse In Alternative Biological Fluids And Tissues
检测替代生物液体和组织中的滥用药物
  • 批准号:
    9352033
  • 财政年份:
  • 资助金额:
    $ 29.98万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.98万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了